Holista Colltech (ASX:HCT) unites with Global Infection Control Consultants to fight coronavirus
- Biotechnology company Holista Colltech (HCT) has announced plans to co-develop and produce a nasal sanitising balm to fight the coronavirus
- The balm will include Path-Away, a compound that has proven effective against some corona-type viruses
- Holista and Global Infection Control Consultants will extend their partnership to develop the balm
- Forums
- ASX - By Stock
- HCT
- Teams up with Global Infection Control Consultants
Teams up with Global Infection Control Consultants
Featured News
Add HCT (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.6¢ |
Change
0.001(20.0%) |
Mkt cap ! $1.673M |
Open | High | Low | Value | Volume |
0.5¢ | 0.6¢ | 0.5¢ | $423 | 73.35K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 38659 | 0.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.6¢ | 647387 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 38659 | 0.005 |
3 | 1800235 | 0.004 |
9 | 9777999 | 0.003 |
2 | 1700000 | 0.002 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.006 | 647387 | 2 |
0.007 | 403091 | 3 |
0.008 | 390000 | 2 |
0.009 | 100000 | 1 |
0.010 | 699060 | 4 |
Last trade - 14.43pm 13/06/2024 (20 minute delay) ? |
Featured News
HCT (ASX) Chart |